Composite probiotic powder for treating calf diarrhea, composite probiotic preparation and preparation method thereof
By regulating the intestinal flora of calves and supplementing electrolytes through compound probiotic powder, the health problems caused by calves diarrhea are solved, and the treatment effect is achieved is achieved with rapid effect and environmentally friendly and safe treatment, avoiding the drug resistance and drug residues of antibiotic use.
Patent Information
- Application Number
- CN202211153121.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-09-21
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2042-09-21
AI Technical Summary
Diarrhea in calf causes intestinal flora disorders and reduced immunity. Existing antibiotic treatments have problems with drug resistance and drug residues, making it difficult to effectively control the disease and affect the development of the dairy industry.
Use the complex probiotic powder of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delhien Bulgarian subspecies to combine prebiotics and electrolytes to regulate the structure of the intestinal bacterial flora, improve immunity, supplement electrolytes, and correct acidosis , treat diarrhea in calves.
It has quick results, good efficacy, reduces drug resistance risks, is environmentally friendly and safe, and has wide adaptability, reducing economic and health losses caused by antibiotic use.
Smart Images

Figure CN115518081B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of composite probiotic powder preparations, in particular to a composite probiotic powder for treating calf diarrhea and a preparation method thereof, as well as a composite probiotic preparation containing the composite probiotic powder and a preparation method thereof. Background Art
[0002] Calf diarrhea refers to a disease in which the intestinal contents and a large amount of water are excreted from the body due to hyperperistalsis and incomplete or difficult absorption of intestinal contents. The feces are thin soup or watery, and the calves are dehydrated and acidotic. The clinical manifestations are depression, high fever, abdominal distension, abdominal pain, loss of appetite, shortness of breath, foul-smelling, black feces, occasionally mixed with blood bubbles, acute and massive watery diarrhea, progressive dehydration, acidosis, etc. It is one of the main diseases that cause poor growth and death in calves. Calf diarrhea can occur all year round, especially in early spring, late summer, and early autumn when the climate is changeable, with a high incidence rate. Calves in lactation are more likely to have diarrhea, accounting for about 80% of the incidence rate of calves. In addition, calves that have had diarrhea are also susceptible to respiratory diseases in the future growth process, which has a great impact on the development, growth, and survival of calves, causing considerable economic losses to the cattle industry.
[0003] At present, antibiotics are mostly used in clinical treatment of calf diarrhea at home and abroad. Commonly used drugs include gentamicin, oxytetracycline, cefoperazone, norfloxacin, fluopicolide, etc. Although antibiotic treatment has certain efficacy, due to the many pathogenic factors of calf diarrhea, antibiotics are not very targeted, and are prone to drug resistance and excessive drug residues in livestock products, which seriously endanger human and animal health and public health safety. Therefore, it is extremely important to effectively control calf diarrhea, reduce drug resistance and antibiotic residues, and develop products with wide adaptability, high efficiency and stability, low drug resistance, and environmental safety to promote the sustainable and healthy development of the dairy industry. Summary of the invention
[0004] In view of the above technical problems, the present invention provides a composite probiotic powder, a composite probiotic preparation and a preparation method thereof for treating calf diarrhea. The composite probiotic powder can regulate the lack of calf intestinal flora and the disordered intestinal flora structure through the combination of specific probiotics, and can also improve the body's immunity, thereby improving the body's health level. The composite probiotic preparation contains the composite probiotic powder, and also contains prebiotics and electrolytes. Through the joint conditioning of probiotics, prebiotics and electrolytes, while exerting the effects of the above-mentioned probiotics, it can also replenish electrolytes lost due to diarrhea, correct intestinal acidosis, and treat calf diarrhea quickly and with good efficacy.
[0005] In order to achieve the above-mentioned object of the invention, the embodiment of the present invention adopts the following technical solution:
[0006] In a first aspect, an embodiment of the present invention provides a composite probiotic powder, wherein raw materials of the composite probiotic powder include Lactobacillus plantarum, Bifidobacterium lactis, Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus.
[0007] Hundreds of millions of microorganisms in the calf's intestines constitute the calf's intestinal flora, which are closely related to the body's normal metabolism. Once the microecological balance in the calf's intestines is destroyed, its flora structure will be affected, and the calf's health will be threatened. Studies have shown that the types and numbers of dominant flora in the intestines of calves with diarrhea are different from those in healthy calves. The difference in bacterial species and structure will directly affect the calf's normal physiological metabolism. Therefore, probiotic preparations used to maintain healthy calves are not suitable for calves with diarrhea.
[0008] The invention can regulate the disordered intestinal flora structure, improve the body's immunity, maintain the intestinal barrier, reduce diarrhea-causing bacteria and inflammatory factors, and thus improve the body's health level through the combined use of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus.
[0009] In conjunction with the first aspect, the plant lactobacillus is plant lactobacillus Lp45. The strain was deposited in the General Microbiological Center of China Microbiological Culture Collection Committee on August 26, 2013, and the deposit address is No. 3, No. 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is CGMCC No.8072. The strain is a disclosed strain, and is disclosed in the patent application text of "a plant lactobacillus and its application" in publication number CN103642716A, and the name of invention is "a plant lactobacillus and its application".
[0010] The survival rate of Lactobacillus plantarum LP45 after 4 hours of digestion in artificial gastric juice with pH 3.0 can reach 122.4%, and the survival rate after 4 hours in liquid culture medium with 0.3% bile salt can reach 47.8%; the adhesion capacity to gastrointestinal epithelial cells is 72, with strong adhesion, and it has a significant inhibitory effect on Escherichia coli and Staphylococcus aureus. Applying it to the probiotic powder can not only make it play a better immunomodulatory role, but also help repair the damaged parts of the intestine.
[0011] In combination with the first aspect, the bifidobacterium is bifidobacterium L531. The strain has been deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration Committee on March 13, 2019, with the deposit address at No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is CGMCC No. 17329. The strain is a published strain, disclosed in the patent application text with the publication number CN113142304A and the invention name "A probiotic composition and application for promoting human metabolism to produce golden stool".
[0012] After digestion in artificial gastric juice at pH 3.0 for 3 hours, the survival rate of Bifidobacterium L531 can still reach more than 90%; after digestion in artificial intestinal juice at pH 8.0 for 5 hours, the survival rate can still reach more than 95%. The teichoic acid produced by the metabolism of Bifidobacterium L531 interacts with the intestinal mucosal epithelial cells and closely combines with other anaerobic bacteria to occupy the surface of the intestinal mucosa, forming a biological barrier, showing strong colonization resistance; the large amount of lactic acid, acetic acid, B vitamins, etc. produced by its metabolism can effectively reduce the intestinal pH, promote the utilization of intestinal iron, calcium and phosphorus elements, and enhance protein decomposition. Bifidobacterium L531 has different degrees of antagonism against intestinal diarrhea-causing strains Shigella dysenteriae, Salmonella typhimurium, Escherichia coli, and Pseudomonas aeruginosa. At the same time, it can also serve as an antigen to stimulate the body's immune response, activate the β-galactosidase activity of macrophages, strengthen and promote phagocytic ability, and put the body in a state of immune surveillance and immune clearance, with an immunomodulatory effect. There is no plasmid DNA in the Bifidobacterium L531 strain, so there is no risk of spreading drug-resistant plasmids in the intestine. Applying it to the probiotic powder helps maintain the biological barrier of the intestinal mucosa, improve the utilization rate of iron and calcium, antagonize intestinal diarrhea-causing strains, and enhance immune regulation.
[0013] In conjunction with the first aspect, the thermophilic streptococcus is thermophilic streptococcus S131. The strain has been deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration Committee on September 1, 2021, with a deposit address of No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and a deposit number of CGMCC No. 23336. The strain is a published strain, disclosed in the patent application text with a publication number of CN113736715A and an invention name of "A strain of thermophilic streptococcus S131 and its application in the field of immunomodulation".
[0014] Streptococcus thermophilus S131 is an oxygen-consuming Gram-positive bacterium that can metabolize glucose, fructose, lactose, sucrose and galactose to produce lactic acid and folic acid. Streptococcus thermophilus S131 has multiple anti-oxidative stress mechanisms and antioxidant capacity in the body. The SOD it secretes has the effect of blocking the secretion of inflammatory factors. Applying it to the probiotic powder is conducive to reducing the production of inflammatory factors.
[0015] In addition, the probiotic powder also uses Lactobacillus delbrueckii subspecies Bulgaria, which can share the ecological environment with Streptococcus thermophilus to produce synergistic effects, and can metabolize and produce a variety of antibiotics, which have a good inhibitory effect on pathogenic bacteria that cause calf diarrhea. This strain can also promote the decomposition of protein and lactose in feeding milk, prolong the circulation time of chyme in the intestine, increase the absorption of nutrients by the intestine, and make the diarrhea calves recover faster.
[0016] Preferably, the ratio of the viable counts of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus is (300-700):(400-800):(50-150):(3-7).
[0017] Preferably, the ratio of the viable counts of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus is (400-600):(500-700):(80-120):(4-6).
[0018] Preferably, the ratio of the viable counts of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus is 500:600:100:5.
[0019] In a second aspect, an embodiment of the present invention further provides a method for preparing the composite probiotic powder: Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus are cultured by high-density fermentation to obtain freeze-dried bacterial powder.
[0020] In a third aspect, an embodiment of the present invention further provides a composite probiotic preparation, the raw materials of which include the composite probiotic powder and prebiotics, electrolytes and dietary fiber. The composite probiotic powder is used in combination with prebiotics, electrolytes and dietary fiber, which can not only exert the above-mentioned effects of the composite probiotic powder, but also replenish electrolytes lost due to diarrhea, correct intestinal acidosis, and make the composite probiotic preparation treat calf diarrhea quickly and with good efficacy.
[0021] In conjunction with the third aspect, the prebiotics include manno-oligosaccharides.
[0022] Manno-oligosaccharides have special glycosidic bonds and cannot be digested by pancreatic amylase in animal organisms. They can directly enter the small intestine and selectively promote the growth of probiotics, especially the growth of Bacillus. At the same time, as a prebiotic, manno-oligosaccharides can specifically bind to most pathogens with exogenous lectins, inhibit the binding of pathogens to receptors in the intestines, further prevent the adhesion of pathogens, and even adsorb and transport pathogens attached to the intestines out of the body, playing a role in protecting the intestines.
[0023] Preferably, the mass percentage of the prebiotics in the composite probiotic preparation is 15-25%.
[0024] In combination with the third aspect, the dietary fiber includes resistant dextrin.
[0025] Resistant dextrin is a molecular water-soluble dietary fiber with unique physiological functions and good processing characteristics. It has good acid and heat stability, strong digestive tolerance, and can improve the composition of animal intestinal flora and absorb harmful substances in the intestine.
[0026] In combination with the third aspect, the electrolyte includes at least one of sodium chloride, potassium chloride, sodium bicarbonate and sodium citrate.
[0027] Sodium chloride is used to supplement the loss of sodium and chloride ions in the body due to calf diarrhea, maintain the stability of the body's internal environment, and stabilize the conduction of electrical signals; potassium chloride is used to supplement the loss of potassium and chloride ions in the body due to calf diarrhea, maintain the stability of the body's internal environment, and the normal operation of the sodium-potassium pump. Sodium bicarbonate and sodium citrate can be used to correct acidosis caused by the loss of electrolytes in diarrheal calves.
[0028] Preferably, the mass percentage of the electrolyte in the composite probiotic preparation is 2-23%.
[0029] Further preferably, in the composite probiotic preparation, the mass percentage of sodium chloride is 7% to 9%, the mass percentage of potassium chloride is 3% to 5%, the mass percentage of sodium bicarbonate is 3% to 5%, and the mass percentage of sodium citrate is 2% to 4%.
[0030] In combination with the third aspect, in the composite probiotic preparation, the amount of the composite probiotic powder is 8 10 ~12 10 CFU / g.
[0031] In combination with the third aspect, the composite probiotic preparation also includes vitamin C and zinc methionine.
[0032] In the fourth aspect, the embodiment of the present invention also provides a method for preparing the above-mentioned composite probiotic preparation: comprising the following operations: accurately weighing the 40-60 mesh powder of the prebiotics, electrolytes, and dietary fiber according to the above-mentioned weight fraction, drying after mixing until the moisture content drops below 5%, and then mixing evenly with the composite probiotic powder. If the moisture content of the prebiotics, electrolytes, and dietary fiber does not exceed 5%, there is no need to dry them. If it exceeds 5%, they are dried to improve the stability of the probiotics and extend the shelf life of the composite probiotic preparation. The material temperature during drying should not be higher than 85°C. After drying to a moisture content of less than 5%, cool to room temperature and mix with the composite probiotic powder. The drying method can adopt boiling drying to improve the drying efficiency.
[0033] The beneficial effects of the present invention are:
[0034] The present invention selects plant lactobacillus, bifidobacterium, thermophilic streptococcus and Lactobacillus delbrueckii subspecies Bulgaria for compatibility. After the compatibility, there is no antagonism between the four bacteria, which is suitable for the special intestinal environment of diarrheal calves, can regulate the disordered intestinal flora structure, improve the body's immunity, maintain the intestinal barrier, reduce diarrhea-causing bacteria and inflammatory factors, and thus improve the body's health level. Furthermore, according to the electrolyte loss of diarrheal calves, the present invention combines modern microbiological research, reasonably matches probiotics, prebiotics, electrolytes and dietary fiber, and prepares a preparation for regulating the intestinal microecology of calves, which can promote calf feeding and growth while treating calf diarrhea and enteritis. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 This is a process flow chart for preparing the composite probiotic preparation in Example 6;
[0036] Figure 2 This is a graph showing the antibacterial effects of various strains on pathogenic bacteria in Effect Example 1;
[0037] Figure 3 This is a graph showing the changes in Escherichia coli after using the composite probiotic preparation of Example 6 in Effect Example 2 for 24 hours. DETAILED DESCRIPTION
[0038] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0039] Example 1
[0040] An embodiment of the present invention provides a composite probiotic powder, including Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subspecies bulgaricus (produced by Hebei Yiran Biotechnology Co., Ltd.), and the ratio of the number of live bacteria is 100:120:20:1.
[0041] Example 2
[0042] An embodiment of the present invention provides a composite probiotic powder, including Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subspecies bulgaricus (produced by Hebei Yiran Biotechnology Co., Ltd.), with a ratio of viable bacteria count of 200:350:40:3.
[0043] Example 3
[0044] An embodiment of the present invention provides a composite probiotic powder, including Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subspecies bulgaricus (produced by Hebei Yiran Biotechnology Co., Ltd.), with a ratio of viable bacteria count of 150:125:40:1.
[0045] Example 4
[0046] The embodiment of the present invention provides a composite probiotic powder, including Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subspecies bulgaricus (produced by Hebei Yiran Biotechnology Co., Ltd.), and the ratio of the number of live bacteria is 300:800:50:7.
[0047] Example 5
[0048] The embodiment of the present invention provides a composite probiotic powder, including Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subspecies bulgaricus (produced by Hebei Yiran Biotechnology Co., Ltd.), and the ratio of the number of live bacteria is 700:400:150:3.
[0049] Example 6
[0050] The present invention provides a composite probiotic preparation, which is made from the following raw materials:
[0051]
[0052] The preparation method of the composite probiotic preparation is as follows: the composite probiotic powder, sodium chloride, potassium chloride, sodium bicarbonate, sodium citrate, zinc methionine, vitamin C, manno-oligosaccharide, and resistant dextrin are crushed and passed through a 40-mesh sieve respectively, the crushed and sieved raw materials are weighed according to the above proportions, sodium chloride, potassium chloride, sodium bicarbonate, sodium citrate, zinc methionine, and resistant dextrin are boiled and dried at 80° C. for 20 minutes (water content <5%), the crushed and sieved composite probiotic powder is added, mixed for 30 minutes, and packaged to obtain the product. The process flow chart of the preparation method is as follows: Figure 1 shown.
[0053] Example 7
[0054] The present invention provides a composite probiotic preparation, which is made from the following raw materials:
[0055]
[0056] The preparation method of the composite probiotic preparation is the same as that of Example 6.
[0057] Example 8
[0058] The present invention provides a composite probiotic preparation, which is made from the following raw materials:
[0059] The composite probiotic powder prepared in Example 3 11×10 10 CFU / g
[0060]
[0061]
[0062] The preparation method of the composite probiotic preparation is the same as that of Example 6.
[0063] Example 9
[0064] The present invention provides a composite probiotic preparation, which is made from the following raw materials:
[0065]
[0066] The preparation method of the composite probiotic preparation is the same as that of Example 6.
[0067] Example 10
[0068] The present invention provides a composite probiotic preparation, which is made from the following raw materials:
[0069]
[0070]
[0071] The preparation method of the composite probiotic preparation is the same as that of Example 6.
[0072] Effect Example 1
[0073] This effect example provides the antibacterial effect of Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subspecies bulgaricus in the above-mentioned composite probiotic powder on pathogenic bacteria, wherein the pathogenic bacteria include enterotoxigenic Escherichia coli (ETEC) and enterohemorrhagic Escherichia coli (EHEC).
[0074] 1. Cultivation of beneficial bacteria (Lactobacillus plantarum Lp45, Bifidobacterium L531, Streptococcus thermophilus S131 and Lactobacillus delbrueckii subsp. bulgaricus)
[0075] Step 1: Prepare the parent culture of beneficial bacteria with MRS broth, inoculate it into another culture medium at a 2% inoculation rate for one generation, and culture three generations in total according to the steps below;
[0076] Step 2: Adjust OD after the third generation 600 = 1 and then cultured at 37°C for 48 hours
[0077] Step 3: Centrifuge at 6000RPM / min for 5 minutes, filter the supernatant through a 0.22-micron filter membrane, and store at 4°C for later use.
[0078] 4.2 Pathogenic bacteria culture
[0079] After preparing the pathogenic bacteria solution, place it in a shaker and adjust the OD 600 =0.1, then dilute 10 times and store at 4℃ for later use.
[0080] 4.3 Oxford cup double-layer agar diffusion method
[0081] Take 10 ml of 2% agar and pour it on the first layer → After the first layer solidifies, use sterilized tweezers to place the Oxford cup on the first layer of agar → Mix 200 ml of solid culture medium + 1 ml of pathogenic bacteria suspension and slowly pour the second layer (15 to 20 ml for each plate) → After the second layer solidifies, remove the Oxford cup, add 100 μl of the prepared beneficial bacteria supernatant to each well, and culture in a 37°C incubator for 10 hours.
[0082] The results are as follows Figure 2 shown.
[0083] Effect Example 2
[0084] This effect example provides the application of the above-mentioned composite probiotic preparation in animal diarrhea.
[0085] Construction of experimental animal diarrhea model: 1000 calves with diarrhea aged 1-60 days were selected from the ranch. The calves with diarrhea were scored and recorded according to the calf diarrhea feces scoring table (as shown in Table 1).
[0086] Table 1 Scoring table for calf diarrhea feces
[0087] Fraction Diarrhea conditions and their respective states 0 No diarrhea; stools are normal and well-formed 1 Mild diarrhea; stools are semi-formed and softer than normal 2 Moderate diarrhea; stool is semi-watery but still contains solid components 3 Severe diarrhea; completely watery stools
[0088] According to the evaluation criteria in Table 1, 20% of the 1000 calves with diarrhea had severe diarrhea (3 points) and 80% had moderate diarrhea (2 points).
[0089] The calves were divided into a positive control group (the treatment drugs were gentamicin and enrofloxacin) and an experimental group, and each group had 20% calves with severe diarrhea and 80% calves with moderate diarrhea.
[0090] The positive control group was first injected intramuscularly with gentamicin injection (0.2 g / 5 mL) at a dose of 0.2 ml per 1 kg of body weight. For calves that still had diarrhea on the third day, enrofloxacin injection (1.0 g / 10 mL) was injected intramuscularly at a dose of 0.05 ml per 1 kg of body weight until the diarrheal calves recovered, that is, the calf feces score was 0 points.
[0091] The experimental group mixed the composite probiotic preparation prepared in Example 6 into normal milk and fed them ad libitum (60 g per day) until the diarrheal calves recovered and met the cure requirement.
[0092] After the experimental group used the composite probiotic preparation of Example 6 for 24 hours, some calves were randomly selected to detect the changes in Escherichia coli. Figure 3 As shown in the figure (the horizontal axis represents the calf number, the number marked "male" represents the male calf, and the number not marked "male" represents the female calf). It should be noted that the Escherichia coli in the calf is a normal strain, which can be divided into neutral bacteria and pathogenic bacteria. Neutral bacteria are not infectious. After testing, the increase in the number of Escherichia coli after feeding (such as 211114, 211114 male, 211112 (1), 211120) is the recovery of the neutral Escherichia coli in the calf, and the increase exceeds the decrease of pathogenic Escherichia coli, which is a normal phenomenon; the decrease in the number of Escherichia coli after feeding is a significant decrease in the pathogenic Escherichia coli in the calf, and the decrease exceeds the increase of neutral Escherichia coli.
[0093] During the feeding period, the number of cured calves was recorded on the 3rd and 5th days, and the cure rate (i.e., calf feces score was 0) was calculated.
[0094] The therapeutic effects of the positive control group and the experimental group are shown in Table 2:
[0095] Table 2 The therapeutic effects of the positive control group and the experimental group
[0096]
[0097] The results showed that the composite probiotic preparation prepared in Example 6 had an excellent therapeutic effect on calf diarrhea.
[0098] On the fifth day of feeding, the calves in the experimental group with severe diarrhea (score of 3 points) were subjected to a quadruple antigen test to detect possible positive pathogenic bacteria, viruses and parasites in their feces. The results are shown in Table 3.
[0099] Table 3 Pathogenic bacteria in feces of calves with severe diarrhea
[0100]
[0101] Comparative Example 1
[0102] This comparative example investigated the use of a single strain in calves with diarrhea.
[0103] 1. Preparation of single-strain inoculants:
[0104] The raw materials of single-strain inoculants include: 10×10 10cfu / g of single strain powder, 8%wt sodium chloride, 4%wt potassium chloride, 4%wt sodium bicarbonate, 3%wt sodium citrate, 0.4%wt zinc methionine, 20% manno-oligosaccharide, and the balance is resistant dextrin. The preparation method is the same as that of Example 6.
[0105] The single strain powders are Lactobacillus plantarum LP45, Lactobacillus plantarum L1016, Bifidobacterium L531, Bifidobacterium longum L1256 and Streptococcus thermophilus S131, which are made into Lactobacillus plantarum LP45 agent, Lactobacillus plantarum L1016 agent, Bifidobacterium L531 agent, Bifidobacterium longum L1256 agent and Streptococcus thermophilus S131 agent respectively.
[0106] 2. Test process
[0107] Forty calves with diarrhea aged 1 to 60 days were selected from the ranch and scored according to the calf diarrhea feces scoring table. The results were: 8 calves scored 3 points and 32 calves scored 2 points.
[0108] The 40 calves with diarrhea were randomly divided into five groups: Lactobacillus plantarum LP45 group, Lactobacillus plantarum L1016 group, Bifidobacterium L531 group, Bifidobacterium longum L1256 group, and Streptococcus thermophilus S131 group. 10 The corresponding single-strain bacterial agent was blended into normal milk at a dose of CFU / g and 60g was fed daily. After 5 days, the calf diarrhea feces scoring table was used to score and count the calves. The number of cured calves was recorded based on the scoring results and the cure rate was calculated, as shown in Table 4.
[0109] Table 4 The cure of diarrhea calves in each group within 5 days
[0110]
[0111] It can be seen from the results that feeding diarrheal calves with a single-strain bacterial agent with the same number of viable bacteria as in Effect Example 2 can have a certain effect in treating calf diarrhea, but the cure rate is low.
[0112] Comparative Example 2
[0113] This comparative example investigated the effect of bacterial agents obtained from different bacterial strain combinations on treating calves with diarrhea.
[0114] 1. Preparation of microbial agent:
[0115] The raw materials of group A bacterial agent include: 10×10 10cfu / g of mixed bacterial powder of plant lactobacillus LP45 and bifidobacterium L531, 8%wt sodium chloride, 4%wt potassium chloride, 4%wt sodium bicarbonate, 3%wt sodium citrate, 0.4%wt zinc methionine, 3% vitamin C, 20% manno-oligosaccharide, and the balance is resistant dextrin. The preparation method of the mixed bacterial powder is the same as that of Example 1, the ratio of the number of viable bacteria of plant lactobacillus LP45 to that of bifidobacterium L531 is 1:1.2, and the preparation method of the bacterial agent is the same as that of Example 6.
[0116] The raw materials of group B bacterial agent include: 10×10 10 cfu / g of mixed bacterial powder of plant lactobacillus LP45 and thermophilic streptococcus S131, 8%wt sodium chloride, 4%wt potassium chloride, 4%wt sodium bicarbonate, 3%wt sodium citrate, 0.4%wt zinc methionine, 3% vitamin C, 20% manno-oligosaccharide, and the balance is resistant dextrin. The preparation method of the mixed bacterial powder is the same as that of Example 1, the ratio of the viable bacterial count of plant lactobacillus LP45 to that of thermophilic streptococcus S131 is 5:1, and the preparation method of the bacterial agent is the same as that of Example 6.
[0117] The raw materials of group C bacterial agent include: 10×10 10 cfu / g of mixed bacterial powder of plant lactobacillus LP45, bifidobacterium L531 and thermophilic streptococcus S131, 8%wt sodium chloride, 4%wt potassium chloride, 4%wt sodium bicarbonate, 3%wt sodium citrate, 0.4%wt zinc methionine, 3% vitamin C, 20% manno-oligosaccharide, and the balance is resistant dextrin. The preparation method of the mixed bacterial powder is the same as that of Example 1, the ratio of the viable counts of plant lactobacillus LP45, bifidobacterium L531 and thermophilic streptococcus S131 is 5:6:1, and the preparation method of the bacterial agent is the same as that of Example 6.
[0118] The raw materials of group D bacterial agent include: 10×10 10 cfu / g of mixed bacterial powder of plant lactobacillus LP45, bifidobacterium L531, thermophilic streptococcus S131 and bacillus subtilis (produced from Hebei Yiran Biotechnology Co., Ltd.), 8%wt sodium chloride, 4%wt potassium chloride, 4%wt sodium bicarbonate, 3%wt sodium citrate, 0.4%wt zinc methionine, 3% vitamin C, 20% manno-oligosaccharide, and the balance is resistant dextrin. The preparation method of the mixed bacterial powder is the same as in Example 1, the ratio of the viable counts of plant lactobacillus LP45, bifidobacterium L531, thermophilic streptococcus S131 and bacillus subtilis is 100:120:20:1, and the preparation method of the bacterial agent is the same as in Example 6.
[0119] 2. Test process
[0120] Calves with diarrhea aged 1 to 60 days were selected from the ranch and scored according to the calf diarrhea feces scoring table. The results were: 8 calves scored 3 points, and 32 calves scored 2 points.
[0121] The above diarrhea calves were randomly divided into 4 groups, namely group A (Lactobacillus plantarum LP45 + Bifidobacterium L531), group B (Lactobacillus plantarum LP45 + Streptococcus thermophilus S131), group C (Lactobacillus plantarum LP45 + Bifidobacterium L531 + Streptococcus thermophilus S131), and group D (Lactobacillus plantarum LP45 + Bifidobacterium L531 + Streptococcus thermophilus S131 + Bacillus subtilis). Each group was treated with 1.0×10 10 The corresponding bacterial agents of each group were blended into normal milk at a dose of CFU / g, and 60g was fed every day. After 5 days, the scores were counted according to the calf diarrhea feces scoring table, and the number of cured calves was recorded according to the scoring results, and the cure rate was calculated, as shown in Table 5.
[0122] Table 5 The cure of diarrhea calves in each group within 5 days
[0123]
[0124]
[0125] It can be seen from the results that feeding diarrhea calves with a bacterial agent made of different probiotics with the same number of viable bacteria as in Example 2 can also have a certain effect in treating calf diarrhea, but the cure rate is lower than that in Example 6.
[0126] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. Use of a composite probiotic preparation in preparing a product for treating calf diarrhea, characterized in that: Its raw materials include compound probiotic powder, prebiotics, electrolytes and dietary fiber; among them, The raw materials of the composite probiotic powder are composed of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus; Wherein, the Lactobacillus plantarum is Lactobacillus plantarum Lp45, and its preservation number is CGMCC No.8072; The bifidobacterium is Bifidobacterium L531, with the accession number of CGMCC No.17329; The thermophilic streptococcus is thermophilic streptococcus S131, with a preservation number of CGMCC No. 23336; The ratio of the viable counts of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus is (300-700): (400-800): (50-150): (3-7); The prebiotics include manno-oligosaccharides; The dietary fiber includes resistant dextrin; The electrolyte includes at least one of sodium chloride, potassium chloride, sodium bicarbonate and sodium citrate.
2. The use of the composite probiotic preparation according to claim 1 in preparing a product for treating calf diarrhea, characterized in that: The ratio of the live bacterial counts of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus is (400-600): (500-700): (80-120): (4-6).
3. The use of the composite probiotic preparation according to claim 2 in preparing a product for treating calf diarrhea, characterized in that: The ratio of the live bacterial counts of Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus is 500:600:100:
5.
4. Use of the composite probiotic preparation according to any one of claims 1 to 3 in the preparation of a product for treating calf diarrhea, characterized in that: The preparation method of the composite probiotic powder comprises: culturing Lactobacillus plantarum, Bifidobacterium, Streptococcus thermophilus and Lactobacillus delbrueckii subspecies bulgaricus through high-density fermentation to obtain freeze-dried bacterial strain powder.
5. The use of the composite probiotic preparation according to claim 1 in preparing a product for treating calf diarrhea, characterized in that: The mass percentage of the prebiotics in the composite probiotic preparation is 15-25%; and / or The mass percentage of the electrolyte in the composite probiotic preparation is 2-23%.
6. Use of the composite probiotic preparation according to claim 1 or 5 in preparing a product for treating calf diarrhea, characterized in that: The preparation method of the composite probiotic preparation comprises the following operations: weighing 40-60 mesh powders of the prebiotics, electrolytes and dietary fiber, mixing and drying until the moisture content is reduced to less than 5%, and then uniformly mixing with the composite probiotic powder.
